Back
BioAtla, Inc. BCAB · Insights
BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on cre... Price1.735
Market Cap2.9 M
Float1.58 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro